T cell-mediated rejection in kidney transplant recipients: The end(point) is also the beginning
- PMID: 35073440
- DOI: 10.1111/ajt.16964
T cell-mediated rejection in kidney transplant recipients: The end(point) is also the beginning
Keywords: clinical research/practice; editorial/personal viewpoint; kidney (allograft) function/dysfunction; kidney transplantation/nephrology; meta-analysis; pathology/histopathology; protocol biopsy; rejection: T cell mediated; rejection: subclinical.
Comment on
-
Effectiveness of T cell-mediated rejection therapy: A systematic review and meta-analysis.Am J Transplant. 2022 Mar;22(3):772-785. doi: 10.1111/ajt.16907. Epub 2021 Dec 10. Am J Transplant. 2022. PMID: 34860468 Free PMC article.
References
REFERENCES
-
- Loupy A, Aubert O, Orandi BJ, et al. Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study. BMJ. 2019;366:l4923.
-
- Rampersad C, Balshaw R, Gibson IW, et al. The negative impact of T cell-mediated rejection on renal allograft survival in the modern era. Am J Transplant. 2021.
-
- Sood P, Cherikh WS, Toll AE, Mehta RB, Hariharan S. Kidney allograft rejection: diagnosis and treatment practices in USA-a UNOS survey. Clin Transplant. 2021;35(4):e14225.
-
- Seifert ME, Yanik MV, Feig DI, et al. Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation. Am J Transplant. 2018;18(9):2189-2199.
-
- Mannon RB, Matas AJ, Grande J, et al. Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant. 2010;10(9):2066-2073.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
